Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (69)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Goebels, N.
Right arrow Articles by Hohlfeld, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goebels, N.
Right arrow Articles by Hohlfeld, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 123, No. 3, 508-518, March 2000
© 2000 Oxford University Press


Invited review

Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects

Epitope spreading versus clonal persistence

Norbert Goebels1,2, Harald Hofstetter1, Stephan Schmidt1, Christoph Brunner1, Hartmut Wekerle1 and Reinhard Hohlfeld1,2

1 Department of Neuroimmunology, Max Planck Institute for Neurobiology, Martinsried and 2 Department of Neurology and Institute for Clinical Neuroimmunology, Ludwig-Maximilians University, Munich, Germany

Correspondence to: Dr Reinhard Hohlfeld, Institute for Clinical Neuroimmunology, Klinikum Grosshadern, Marchioninistrasse 15, D-81366 Munich, Germany E-mail: hohlfeld{at}neuro.mpg.de

Autoantigen-specific T-lymphocytes are present in patients with autoimmune disease and in normal subjects. Little is currently known about the temporal variation (dynamics) of the immune repertoire of these autoreactive T cells. We analysed the long-term variation of the immune repertoire of T cells specific for myelin basic protein (MBP) in five untreated patients with multiple sclerosis and four normal control subjects over a mean observation period of 6 years. MBP-specific CD4+ T-cell lines were selected with purified human MBP, and their epitope specificity was mapped with overlapping synthetic peptides. Three distinct patterns of repertoire development were observed. (i) Two patients and three control subjects maintained a broad epitope response with fluctuations over time. (ii) Two patients initially showed a focused response that broadened over the course of 6 years; this finding could be described as intramolecular epitope spreading. (iii) In one patient and one control subject, a strikingly focused response, which was directed to a cluster of nested epitopes in the MBP region 83–102, persisted over time. T-cell receptor Vß sequence analysis allowed us to trace individual clones of MBP-specific T cells for up to 7 years in the peripheral circulation in four of the five patients and three of the four controls, suggesting that the long-term persistence of MBP-specific T-cell clones is a common feature of the T-cell repertoire not unique to multiple sclerosis. The persisting MBP-specific T-cell clones were not detectable in the blood of one of the patients by complementarity-determining region (CDR)-3 spectratyping, indicating that their frequency does not exceed 1 in 5000 T cells. The temporal characteristics of the MBP-specific T-cell repertoire described here are relevant to therapeutic strategies targeting autoantigen-specific T cells in multiple sclerosis and other autoimmune diseases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
R. Verbeek, H. van Dongen, E. F. Wawrousek, S. Amor, and J. M. van Noort
Induction of EAE by T cells specific for alpha B-crystallin depends on prior viral infection in the CNS
Int. Immunol., March 1, 2007; 19(3): 277 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Ercolini and S. D. Miller
Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease
J. Immunol., March 15, 2006; 176(6): 3293 - 3298.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. A. Deeg, B. Amann, A. J. Raith, and B. Kaspers
Inter- and Intramolecular Epitope Spreading in Equine Recurrent Uveitis
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 652 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kawakami, F. Odoardi, T. Ziemssen, M. Bradl, T. Ritter, O. Neuhaus, H. Lassmann, H. Wekerle, and A. Flugel
Autoimmune CD4+ T Cell Memory: Lifelong Persistence of Encephalitogenic T Cell Clones in Healthy Immune Repertoires
J. Immunol., July 1, 2005; 175(1): 69 - 81.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
I R Moldovan, R A Rudick, A C Cotleur, S E Born, J-C Lee, M T Karafa, and C M Pelfrey
Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing-remitting multiple sclerosis patients
Multiple Sclerosis, June 1, 2005; 11(3): 251 - 260.
[Abstract] [PDF]


Home page
J. Immunol.Home page
S. Ellmerich, M. Mycko, K. Takacs, H. Waldner, F. N. Wahid, R. J. Boyton, R. H. M. King, P. A. Smith, S. Amor, A. H. Herlihy, et al.
High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model
J. Immunol., February 15, 2005; 174(4): 1938 - 1946.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Hohlfeld and H. Wekerle
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines
PNAS, October 5, 2004; 101(suppl_2): 14599 - 14606.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. P. Crawford, S. X. Yan, S. B. Ortega, R. S. Mehta, R. E. Hewitt, D. A. Price, P. Stastny, D. C. Douek, R. A. Koup, M. K. Racke, et al.
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
Blood, June 1, 2004; 103(11): 4222 - 4231.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Skulina, S. Schmidt, K. Dornmair, H. Babbe, A. Roers, K. Rajewsky, H. Wekerle, R. Hohlfeld, and N. Goebels
Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood
PNAS, February 24, 2004; 101(8): 2428 - 2433.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Bradl and R Hohlfeld
Molecular pathogenesis of neuroinflammation
J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1364 - 1370.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. Berger, P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer, and M. Reindl
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event
N. Engl. J. Med., July 10, 2003; 349(2): 139 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Veldman, A. Stauber, R. Wassmuth, W. Uter, G. Schuler, and M. Hertl
Dichotomy of Autoreactive Th1 and Th2 Cell Responses to Desmoglein 3 in Patients with Pemphigus Vulgaris (PV) and Healthy Carriers of PV-Associated HLA Class II Alleles
J. Immunol., January 1, 2003; 170(1): 635 - 642.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Mizrahi, E. Hauben, and M. Schwartz
The Tissue-Specific Self-Pathogen Is the Protective Self-Antigen: The Case of Uveitis
J. Immunol., November 15, 2002; 169(10): 5971 - 5977.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
L. Weiner, N. Kachuck, W. Gilmore, and B. Lund
Immunological aspects of secondary progressive multiple sclerosis
Multiple Sclerosis, September 1, 2002; 8(1_suppl): 83 - 84.
[PDF]


Home page
BrainHome page
M. Jacobsen, S. Cepok, E. Quak, M. Happel, R. Gaber, A. Ziegler, S. Schock, W. H. Oertel, N. Sommer, and B. Hemmer
Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients
Brain, March 1, 2002; 125(3): 538 - 550.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
L P Weiner, N J Kachuck, W Gilmore, and B Lund
Immunological aspects of secondary progressive multiple sclerosis
Multiple Sclerosis, February 1, 2002; 8(1): 83 - 84.
[PDF]


Home page
BloodHome page
R. K. Burt, S. Slavin, W. H. Burns, and A. M. Marmont
Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?
Blood, February 1, 2002; 99(3): 768 - 784.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. A. Muraro, K.-P. Wandinger, B. Bielekova, B. Gran, A. Marques, U. Utz, H. F. McFarland, S. Jacobson, and R. Martin
Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders
Brain, January 1, 2002; 126(1): 20 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Kipnis, E. Yoles, H. Schori, E. Hauben, I. Shaked, and M. Schwartz
Neuronal Survival after CNS Insult Is Determined by a Genetically Encoded Autoimmune Response
J. Neurosci., July 1, 2001; 21(13): 4564 - 4571.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Babbe, A. Roers, A. Waisman, H. Lassmann, N. Goebels, R. Hohlfeld, M. Friese, R. Schroder, M. Deckert, S. Schmidt, et al.
Clonal Expansions of CD8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction
J. Exp. Med., August 8, 2000; 192(3): 393 - 404.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.